Trends in gynaecologic cancer mortality and the impact of the COVID-19 pandemic in the United States.

"Declarations Ethics approval and consent to participateSince all data from NVSS were publicly available and completely de-identified, the study did not seek approval from the institutional review board. Consent for publicationAll authors have read the manuscript and approved the submission. Competing interestsFJ: Speaker: Gilead Sciences, MSD and Ascletis. Consulting/advisory board: Gilead, MSD. All other authors do not have conflict of interest. Transparency statementThe lead author affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. Competing interests FJ: Speaker: Gilead Sciences, MSD and Ascletis. Consulting/advisory board: Gilead, MSD. All other authors do not have conflict of interest."

"Funding This work was supported by The Shaanxi Provincial Key R&D Program (grant no. 2017ZDXM‑SF‑26‑3) and The National Natural Science Foundation of China (grant no. 81702578). The funding body did not play any roles in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript."